Clinical Trials
3
Active:0
Completed:1
Trial Phases
3 Phases
Phase 1:1
Phase 2:1
Not Applicable:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Not Applicable
1 (33.3%)Phase 1
1 (33.3%)Phase 2
1 (33.3%)Spinal Cord Innovation in Pediatrics (SCiP) to Treat SensoriMotor Function in Children Cerebral Palsy: Protocol for a Randomized Controlled Trial
Phase 2
Not yet recruiting
- Conditions
- Cerebral Palsy
- First Posted Date
- 2023-02-09
- Last Posted Date
- 2023-02-09
- Lead Sponsor
- SpineX Inc.
- Target Recruit Count
- 60
- Registration Number
- NCT05720208
Spinal COrd NeuromodulaTor by SpIneX and ScoNE to Treat NeurogeniC BladdEr - SCONE "CONTINENCE" Clinical Study
Not Applicable
Completed
- Conditions
- StrokeMultiple SclerosisSpinal Cord Injuries (Complete and Incomplete)Neurogenic Bladder
- First Posted Date
- 2022-03-29
- Last Posted Date
- 2025-02-17
- Lead Sponsor
- SpineX Inc.
- Target Recruit Count
- 126
- Registration Number
- NCT05301335
- Locations
- 🇺🇸
Rancho Research Institute, Downey, California, United States
🇺🇸UC San Diego Health Systems, San Diego, California, United States
🇺🇸Craig Hospital, Denver, Colorado, United States
Noninvasive Spinal Neuromodulation Enables Locomotor Recovery in Individuals With Cerebral Palsy
Phase 1
Recruiting
- Conditions
- Cerebral Palsy
- First Posted Date
- 2021-05-12
- Last Posted Date
- 2023-04-04
- Lead Sponsor
- SpineX Inc.
- Target Recruit Count
- 50
- Registration Number
- NCT04882592
- Locations
- 🇺🇸
SpineX, Los Angeles, California, United States
News
No news found